Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus

Author:

Rees Sophie1,Arnold Susanne2,Kherlopian Ashod3,Fischer Gayle3

Affiliation:

1. Bristol Trials Centre, University of Bristol, Bristol, UK

2. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK

3. Sydney Medical School, University of Sydney, Sydney, Australia

Abstract

Objectives Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted. Methods Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory. Results All participants had accepted a proactive regimen. Three themes were developed from the analysis: “Coming to accept proactive therapy,” “Motivators to maintaining a proactive regimen,” and “The importance of a routine that fits me.” Within each theme are subthemes illustrating different dimensions of the theme. Conclusions Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference21 articles.

1. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018;Br J Dermatol,2018

2. Evidence-based (S3) guideline on (anogenital) lichen sclerosus;J Eur Acad Dermatol Venereol,2017

3. Vulvar lichen sclerosus: current perspectives;Int J Womens Health,2020

4. Living with vulval lichen sclerosus: a qualitative interview study;Br J Dermatol,2022

5. Silent no more! The lived experiences of women with lichen sclerosis;J Am Acad Nurse Pract,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3